Massive 23,000-Patient study tests new stroke drug in hospitals nationwide
Disease control
Completed
This large study observed how a clot-dissolving drug called non-immunogenic staphylokinase worked for patients having a stroke in real hospital settings. It involved over 23,000 adults who received the drug within 4.5 hours of their stroke symptoms starting. The main goal was to …
Sponsor: Supergene, LLC • Aim: Disease control
Last updated Mar 30, 2026 14:30 UTC